On the specific effectiveness, and under-valuing, of pharmacological treatments for addiction: A comparison of methadone, naltrexone and disulfiram with psychosocial interventions

Addiction Research and Theory

Volumn 3, Issue 4, 1996, Pages 297-313

  Brewer, Colin ^a  

^a Stapleford Centre   (United Kingdom)

Author keywords

Addiction treatment; Medical practice; Methadone; Replacement therapy

Indexed keywords

EID: 2842593890     PISSN: 16066359     EISSN: None     Source Type: Journal    
DOI: 10.3109/16066359609005244     Document Type: Review

References (107)

1. Abed, R. T. and Neira-Munoz, E. (1990) A survey of general practitioners' opinion and attitude to drug addicts and addiction. British Journal of Addiction, 85, 131-136
2. Alcoholics Anonymous (1975) Living Sober. p. 60. London. Jupiter.
3. Andersen, M. P. (1992) Lack of bioequivalence between disulfiram formulations, exemplified by a tablet/effervescent tablet study. Acta Psychiatrica Scandinavica, 86, 31-35.
4. Anglin, M. D. and McGlothlin, W. (1994) Outcome of narcotic addict treatment in California. In F. Tims and J. Lundford (eds.), Drug abuse treatment evaluation: strategies progress and prospects: 106-128. NIDA Research Monograph 51, DHHS Publication no. (ADM) 84-1349. Rockville MD: NIDA
5. Atkinson, R. L., Berke, L. K., Drake, et al. (1985) Effects of long term therapy with naltrexone on body weight in obesity. Clinical Pharmacology and Therapeutics, 38, 419-22.
6. Azrin, N. H., Sissons, R. W., Mayer, S. R. and Godley, M. (1982) Alcoholism treatment by disulfiram and community reinforcement therapy. Journal of Behaviour Therapy & Experimental Psychiatry, 13, 105-12.
7. Azrin, N. H. (1993) Disulfiram and behaviour therapy: a social-biochemical model of alcohol abuse and treatment. In: C. Brewer (ed.) Treatment Options in Addiction - Medical management of alcohol and opiate abuse. London. Gaskell/Royal College of Psychiatrists. 19-28.
8. Babow, I. (1975) The Ireatment monopoly in alcoholism and drug dependence: a sociological critique. Journal of Drug Issues, 5, 120-128.
9. Bale, R., Van Stone, W., Kuldau, J., Engelsing, T., Elashoff, R. and Zarcone, V. (1980) Therapeutic communities vs methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up. Archives of General Psychiatry, 37, 179-93.
10. Ball, J. and Ross, A. (1991) The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. New York. Springer Verlag.
11. Bammer, G. and Gerrard, G. (eds) (1992) Heroin treatment - new alternatives. Proceedings of a One-day seminar, Becker House, Canberra.
12. Battersby, M., Farrell, M., Gossop, M., Robson, P. and Strang, J. (1992) 'Horse-trading': prescribing injectable opiates to opiate addicts. A descriptive study. Drug and Alcohol Review, 11, 35-12.
13. Bell, J., Bowron, P., Lewis, J. and Batey, J. (1990) Serum levels of methadone in maintenance clients who persist in illicit drug use. British Journal of Addiction, 85, 1599-1602.
14. Berridge, V. and Edwards, G. (1987) Opium and the people. New Haven: Yale University Press.
15. Brahen, L., Henderson, R., Capone, T. et al. (1984) Naltrexone treatment in a jail work release program. Journal of Clinical Psychiatry, 45, 49-52.
16. Brewer, C. and Perrett, L. (1971) Brain damage due to alcohol consumption: an air-encephalographic, psychometric and EEG study. British Journal of Addiction, 66, 170-82.
17. Brewer, C. and Lait, J. (1980) Some facts of therapeutic life. In: Can Social Work Survive? Temple Smith, London.
18. Brewer, C. (1984) How effective is the standard dose of disulfiram? A review of the disulfiram-alcohol reaction in practice. British Journal of Psychiatry, 144, 200-202.
19. Brewer, C., Rezae, H. and Bailey, C. (1988a) Opioid withdrawal and naltrexone induction in 48-72 hours using a modification of the naltrexone-clonidine technique. British Journal of Psychiatry, 153, 340-3.
20. Brewer, C. (1988b) Doctors heal the parts ordinary health-professionals cannot reach. Journal of the Royal Society of Health, 108, (1) 15-19.
21. Brewer, C. (1990) Combining pharmacological antagonists and behavioural psychotherapy in treating addictions: why it is effective but unpopular. British Journal of Psychiatry, 157, 34-40.
22. Brewer, C. (1991) In: N. Loimer, R. Schmid and A. Springer (eds.) Intravenous Methadone Maintenance: A British Response to Persistent Opiate Injectors. Drug Addiction and AIDS. 187-199 Springer Verlag. New York.
23. Brewer, C. (1993a) Invited Review: Recent Developments in Disulfiram Treatment. Alcohol & Alcoholism, 28:4, 383-395.
24. Brewer, C. (1993b) Long-term, high-dose disulfiram in the treatment of alcohol abuse. British Journal of Psychiatry, 163, 687-89.
25. Brewer, C. (1993c) What the textbooks say about disulfiram: a review of recent publications. In: C. Brewer (ed.) Treatment Options in Addiction - Medical management of alcohol and opiate abuse. London. Gaskell/Royal College of Psychiatrists.
26. Brewer, C. (1993d) Hair Analysis as a tool for monitoring and managing patients on methadone maintenance. A discussion. Forensic Science International, 63, 277-283.
27. Brickman, B. (1988) Psychoanalysis and substance abuse: toward a more effective approach. Journal of the American Academy of Psychoanalysis, 16, 359-79.
28. Caplehorn, J., Dalton, S., Cluff, M. and Petrenas, A.-M. (1994) Retention in methadone maintenance and heroin addicts' risk of death. Addiction, 89, 203-7.
29. Caplehorn, J. (1995) Methadone maintenance treatment: Britain has been over-committed to psychological theories of drug dependence. British Medical Journal, 310, 463.
30. Chick, J., Gough, K., Wojciech, F. et al. (1992) Disulfiram treatment of alcoholism. British Journal of Psychiatry, 161, 84-89.
31. Christensen, J. K., Meller, I. W., Ronsted, P. et al. (1991) Dose-effect relationship of disulfiram in human volunteers. I: clinical studies. Pharmacology and Toxicology, 68, 163-165.
32. Davidson, K. (1993) Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. British Journal of Psychiatry, 166, 199-204.
33. Dirks, J. (1990) The efficacy of the Amsterdam morphine-dispensing programme. In: H. Ghodse, C. Kaplan and R. Mann (Eds.) Drug Misuse and Dependence. Parthenon. Carnforth.
34. Dole, V. (1965) Thoughts on narcotic addiction. Bulletin of the New York Academy of Medicine, 41, 211-3.
35. Dole, V. (1989) Methadone treatment and the acquired immunodeficiency syndrome epidemic. Journal of American Medical Association, 262(12), 1681-2.
36. Dole, V. (1994) Methadone maintenance: optimising dosage by estimating plasma level. Journal of Addictive Diseases, 13, 1-4.
37. Durlak, J. (1979) Comparative effectiveness of professional and paraprofessional helpers. Psychological Bulletin, 86, 80-92.
38. Edwards, G., Orford, J., Egert, S. et al. (1977) Alcoholism: A controlled Trial of "treatment" and "advice". Quarterly Journal of Studies of Alcohol, 38, (5) 1004-1031.
39. Farrell, M., Ward, J., Mattick, R., Hall, W, Stimson, G., Des Jarlais, D., Gossop, M. and Strang, J. (1994) Methadone maintenance treatment in opiate dependence: a review. British Medical Journal, 309, 997-1001.
40. Friedman, P., Des Jarlais, D. C., Peyser, N. P. et al. (1994) Retention of patients who entered methadone maintenance via an interim methadone clinic. Journal of Psychoactive Drugs, 26, 217-21.
41. Galanter, M. (1993) Network therapy for addiction: a model for office practice. American Journal of Psychiatry, 150, 28-36.
42. Gelder, M. G., Marks, I. and Wolff, H. H. (1967) Desensitisation and psychotherapy in the treatment of phobic states: a controlled clinical enquiry. British Journal of Psychiatry, 113, 53-73.
43. Gerra, G., Marcato, A., Caccavari, R. et al. (1995) Clonidine and opiate receptor antagonists in the treatment of heroin addiction. Journal of Substance Abuse Treatment, 12, 35-411.
44. Goldstein, A., Hansteen, R., Horns, W. (1975) Control of methadone dosage by patients. Journal of the American Medical Association, 234, 734-7.
45. Gossop, M., Green, L. and Phillips, G. (1987) What happens to opiate addicts immediately after treatment: a prospective follow-up study. British Medical Journal, 294, 1377-80.
46. Gottheil, E., Sterling, R. and Weinstein, S. (1993) Diminished illicit drug use as a consequence of long-term methadone maintenance. Journal of Addictive Diseases, 12, 45-57.
47. Greenwood, J. (1992) Persuading general practitioners to prescribe - good husbandry or a recipe for chaos? British Journal of Addiction, 87(4), 567-75.
48. Gronbladh, L. and Gunne, L. (1981) The Swedish methadone maintenance program: a controlled study. Drug and Alcohol Dependence, 7, 249-56.
49. Gunne, L. (1990) Politicians and scientists in the combat against drug abuse. Drug and Alcohol Dependence, 25, 241-244.
50. Haemmig, R. (1995) Harm reduction in Bern: from outreach to heroin maintenance. Bulletin of the New York Academy of Medicine. 371-9.
51. Harrison, L. (1992) Substance misuse and social work qualifying training in the British Isles: a survey of CQSW courses. British Journal of Addiction, 87, 635-42.
52. Hartnoll, R., Mitcheson, M. and Battersby, A. (1980) Evaluation of heroin maintenance in a controlled trial. Archives of General Psychiatry, 37, 877-884.
53. Havassy, B. and Hargreaves, W. (1981) Allowing methadone clients control over dosage: a 48-week controlled trial. Addictive Behaviors, 6, 283-288.
54. Heather, N. (1989) Disulfiram treatment for alcoholism. Does it deserve another chance? British Medical Journal, 299, 471-472.
55. Holmstrand, J., Anggard, E. and Gunne, L. (1978) Methadone maintenance: plasma levels and therapeutic outcome. Clinical Pharmacology and Therapeutics, 21, 175-80.
56. Huxley, P. (1985) Social work practice in mental health. Gower. Aldershot.
57. Jensen, E. (1984) A proper use of Antabuse: the Danish model of treatment. British Journal of Clinical Practice, 38, (Suppl. 36) 117-122.
58. Johansson, B., Angelo, H., Christensen, J., Moller, I. and Ronsted, P. (1991) Dose-effect relationship of disulfiram in human volunteers II: a study of the relationship between the disulfiram-alcohol reaction and plasma concentrations of acetaldehyde, diethyldithiocarbamic acid methyl ester and erythrocyte aldehyde dehydrogenase activity. Pharmacology and Toxicology, 68, 166-70.
59. Johnsen, J. and Morland, J. (1992) Depot preparations of disulfiram: experimental and clinical results. Acta Psychiatrica Scandinavica, 86, 27-30.
60. Kaaber, K., Menne, T., Veien, N. and Baadsgaard, O. (1987) Some adverse effects of disulfiram in the treatment of nickel-allergic patients. Dermatosen Beruf Umwelt, 38, 209-211.
61. Keso, L. and Salaspuro, M. (1990) In-patient treatment of employed alcoholics: a randomised trial of Hazelden-type and traditional treatments. Alcoholism: Clinical and Experimental Research, 14, 584-9.
62. Kleber, H. D. and Kosten, T. R. (1984) Naltrexone induction: psychologic and pharmacologie strategies. Journal of Clinical Psychiatry, 45, 29-38.
63. Kreek, M. (1992) Rationale for maintenance pharmacotherapy of opiate dependence. In: O'Brien, C. and Jaffe, J. (Eds.) Addictive States. 205-30. Raven Press. New York.
64. Kwentus, J. and Major, L. (1979) Disulfiram in the treatment of alcoholism: a review. Journal of Studies on Alcohol, 40, 428-39.
65. Legarda, J. and Gossop, M. (1994) A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug and Alcohol Dependence, 35, 91-93.
66. Liappas, I. et al. (1987) Thoughts on the Sheffield non-prescription programme for narcotic users. British Journal of Addiction, 82, 999-1006.
67. Loimer, N., Schmid, R., Lenz, K., Presslich, O. and Grunberger, J. (1990) Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. British Journal of Psychiatry, 157, 748-752.
68. Loimer, N. and Schmid, R. (1992) The use of plasma levels to optimise methadone maintenance treatment. Drug and Alcohol Dependence, 30, 241-246.
69. Loimer, N., Lenz, K., Schmid, R., Presslich, O. (1991a) Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. American Journal of Psychiatry, 148, 933-935.
70. Loimer, N., Linzmayer, L., Grunberger, J. (1991b) Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification. Drug and Alcohol Dependence, 28, (3) 265-268.
71. MacDonald, G., Sheldon, B., Gillespie, J. (1992) Contemporary studies of the effectiveness of social work. British Journal of Social Work, 22, 615-643.
72. Maddux, J., Esquivel, M., Vogtsberger, K. and Desmond, D. (1991) Methadone dose and urine morphine. Journal of Substance Abuse and Treatment, 8, 195-201.
73. Mathew, R. J., Georgi, J. and Nagy, P. (1994) Substance abuse treatment: beyond the Minnesota Model. North Carolina Medical Journal, 55, 224-6.
74. Meyers, R. (1995) The community reinforcement approach: a systematic cognitive-behaviour therapy for addictive behaviours. Paper presented at 7th International conference on the treatment of addictive behaviours. Leeuwenhorst. The Netherlands. May 28.
75. Miller, W. (1992) The effectiveness of treatment for substance abuse: reasons for optimism. Journal of Substance Abuse Treatment, 9, 93-102.
76. Miller, W. and Hester, R. (1986a) The effectiveness of alcoholism treatment: what research reveals. In Miller, W., Heather, N., Eds. The addictive behaviours: processes of change New York: Plenum Books.
77. Miller, W. and Hester, R. (1986b) In-patient alcoholism treatments: who benefits? American Psychologist, 41, 794-805.
78. Najavits, L. and Weiss, R. (1994) Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. Addiction, 89, 679-88.
79. Newman, R. and Whitehill, W. (1979) Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet, 2, 485-88.
80. Ojehagen, A. and Berglund, M. (1986) To keep the alcoholic in out-patient treatment. A differentiated approach through treatment contracts. Acta Psychiatrica Scandinavica, 73 (1), 68-75.
81. O'Malley, S. S., Jaffe, A. J., Chang, G. et al. (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry, 49, 881-7.
82. Phillips, M. (1990) Disulfiram-induced fulminating hepatitis and monitoring guidelines. Journal of Clinical Psychiatry, 51, 168.
83. Phillips, M. and Greenberg, J. (1992) Dose-ranging study of depot disulfiram in alcohol abusers. Alcoholism: Clinical & Experimental Research, 16, 964-967.
84. Pini, L., Ferretti, C., Trenti, T. et al. (1991) Effects of long term treatment with naltrexone on hepatic enzyme activity. Drug Metabolism and Drug Interactions, 9, 161-174.
85. Poulsen, E. H., Loft, S., Andersen, J. R. and Andersen, M. (1992) Disulfiram therapy - adverse drug reactions and interactions. Acta Psychiatrica Scandinavica, 86, 59-66.
86. Price, J. (1994) Abstinence and Antabuse: symbolism and supervision. Medical Journal of Australia, 160, 175.
87. Prioleau, L., Murdock, M. and Brody, N. (1983) An analysis of psychotherapy versus placebo studies. The Behavioral and Brain Sciences, 6, 275-310.
88. Ron, M. A. (1977) Brain damage in chronic alcoholism: a neuropathogical, neuroradiological and psychological review. Psychological Medicine, 7, 103-11.
89. Salmela, K., Keso, L. and Salaspuro, M. (1993) A randomized clinical trial on Hazelden-type and traditional inpatient treatment for alcoholism: long term outcome. Paper presented at ICTAB VI, Santa Fé, January 1993.
90. Saunders, B. (1985) Treatment does not work: some criteria of failure. In: (Eds: Heather, N., Robertson, I. and Davies, P.) The Misuse of Alcohol: Crucial Issues in Dependence, Treatment & Prevention, pp. 112-116. London: Croom Helm.
91. Sereny, G., Sharma, V., Holt, J. and Gordis, E. (1986) Mandatory supervised Antabuse therapy in an out-patient alcoholism program: a pilot study. Alcoholism: Clinical & Experimental Research, 10, 290-92.
92. Sheldon, B. (1978) Theory and practice in social work: a re-examination of a tenuous relationship. British Journal of Social Work, 8, 1-22.
93. Schuckit, M. A. (1994) Alcohol and depression: a clinical perspective. Acta Psychiatrica Scandinavica, Suppl., 377, 28-32.
94. Shufman, E. N., Porat, S., Witztum, E., Bar-Hamburger, R., Gandacu, D. (1994) The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry, 35, 935-45.
95. Sloane R., Staples, R, Cristol, A., Yorkston, N. and Whipple, K. (1975) Psychotherapy versus Behaviour Therapy. Cambridge, Mass. Harvard University Press.
96. Strain, E. C, Stitzer, M. L., Liebson, I. and Bigelow, G. E. (1993a) Dose-Response Effects of Methadone in the Treatment of Opioid Dependence. Annals of internal Medicine, 119, 23-27.
97. Strain, E. C., Stitzer, M., Liebson, I. and Bigelow, G. (1993b) Methadone dose and treatment outcome. Drug and Alcohol Dependence, 33, 105-17.
98. Strang, J. and Farrell, M. (1992) Alcohol and drugs. British Medical Journal, 304, 489.
99. Strang, J., Ruben, S., Farrell, M. and Gossop, M. (1994) Prescribing heroin and other injectable drugs. In: Strang, J. and Gossop, M. (Eds.) Heroin Addiction and Drug Policy: the British system. Oxford University Press. Oxford.
100. Strupp, H. and Hadley, S. (1979) Specific versus non-specific factors in psychotherapy: a controlled study of outcome. Archives of General Psychiatry, 36, 1125-36.
101. Tilly, J., Cornish, J., Metzger, D. S., Woody, G. E., McLellan, A. T. and O'Brien, C. P. (1991) Naltrexone and the treatment of federal probationers. NIDA Research Monograph, 119, 458.
102. Vailliant, G. (1983) Natural history of male alcoholism, V: is alcoholism the cart or the horse to sociopathy? British Journal of Addiction, 78, 317-26.
103. Vanichseni, S. and Wongsuwan, B. (1991) A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: implications for prevention of HIV. International Journal of Addictions, 26, 1313-20.
104. Washton, A. M., Pottash, A. C. and Gold, M. S. (1984) Naltrexone in addicted business executives and physicians Journal of Clinical Psychiatry, 45 (9), 511-5.
105. Weinstein, S. P., Gottheil, E., Sterling, R. C. and De Maria, P. A. (1993) Long-Term Methadone Maintenance Treatment: Some Clinical Examples, Journal of Substance Abuse Treatment, 10, 277-281.
106. Wright, C., Vafir, J. A. and Lake, C. (1988) Disulfiram-induced fulminating hepatitis: guidelines for liver-panel monitoring. Journal of Clinical Psychiatry, 49, 430-34.
107. Yancovitz, S., Des Jarlais, D., Peyser, N., Drew, E., Friedman, P. and Trigg, H. (1991) A randomised trial of an interim methadone maintenance clinic. American Journal of Public Health, 81, 1185-91.